Search Results - "Guglielmetti, L"

Tailored TPT for drug-resistant TB - promoting equity and access to optimal care by Khan, U., Guglielmetti, L.

Get full text

Evidence and ethical considerations for the treatment of contacts exposed to drug-resistant TB by Khan, U., Guglielmetti, L.

Get full text

On the use of gravity data in delineating geologic features of interest for geothermal exploration in the Geneva Basin (Switzerland): prospects and limitations by Guglielmetti, L., Moscariello, A.

“…Gravity data retrieved from the Bureau Gravimétrique International and the Gravimetric Atlas of Switzerland have been used to evaluate their applicability as a…”
Get full text

Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis by Lan, Zhiyi, Ahmad, Nafees, Baghaei, Parvaneh, Barkane, Linda, Benedetti, Andrea, Brode, Sarah K, Brust, James C M, Campbell, Jonathon R, Chang, Vicky Wai Lai, Falzon, Dennis, Guglielmetti, Lorenzo, Isaakidis, Petros, Kempker, Russell R, Kipiani, Maia, Kuksa, Liga, Lange, Christoph, Laniado-Laborín, Rafael, Nahid, Payam, Rodrigues, Denise, Singla, Rupak, Udwadia, Zarir F, Menzies, Dick, Ahmad, N, Baghaei, P, Barkane, L, Benedetti, A, Brode, SK, Brust, JCM, Campbell, JR, Chang, VWL, Falzon, D, Guglielmetti, L, Isaakidis, P, Kempker, RR, Kipiani, M, Kuksa, L, Lan, Z, Lange, C, Laniado-Laborín, R, Nahid, P, Rodrigues, D, Singla, R, Udwadia, ZF, Menzies, D

“…Treatment of multidrug-resistant tuberculosis requires long-term therapy with a combination of multiple second-line drugs. These drugs are associated with…”
Get full text

Diaphragmatic Hernia After Laparoscopic Gastric Bypass Surgery by Guglielmetti, L. C., Wyss, R., Biraima, M., Misirlic, M., Peros, G.

Get full text

Reply to: "Human rights: finding the right balance for rifampicin-resistant TB treatment" by Cox, V., Guglielmetti, L., Hewison, C., Reuter, A., Furin, J.

Get full text

Clinical management of adults and children with multidrug-resistant and extensively drug-resistant tuberculosis by Dheda, K., Chang, K.C., Guglielmetti, L., Furin, J., Schaaf, H.S., Chesov, D., Esmail, A., Lange, C.

“…Globally there is a burgeoning epidemic of drug monoresistant tuberculosis (TB), multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB)…”
Get full text

Management of patients with multidrug-resistant tuberculosis by Lange, C., Aarnoutse, R. E., Alffenaar, J. W. C., Bothamley, G., Brinkmann, F., Costa, J., Chesov, D., van Crevel, R., Dedicoat, M., Dominguez, J., Duarte, R., Grobbel, H. P., Günther, G., Guglielmetti, L., Heyckendorf, J., Kay, A. W., Kirakosyan, O., Kirk, O., Koczulla, R. A., Kudriashov, G. G., Kuksa, L., van Leth, F., Magis-Escurra, C., Mandalakas, A. M., Molina-Moya, B., Peloquin, C. A., Reimann, M., Rumetshofer, R., Schaaf, H. S., Schön, T., Tiberi, S., Valda, J., Yablonskii, P. K., Dheda, K.

“…The emergence of multidrug-resistant tuberculosis (MDR-TB; defined as resistance to at least rifampicin and isoniazid) represents a growing threat to public…”
Get full text

TB research requires strong protections, innovation, and increased funding in response to COVID-19 by Nyang'wa, B. T, LaHood, A. N, Mitnick, C. D, Guglielmetti, L

“…Strategies include establishing alternate locations for in-person visits; increased use of remote, virtual visits including video observation for treatment…”
Get full text

Integration of 3D geological modeling and gravity surveys for geothermal prospection in an Alpine region by Guglielmetti, L., Comina, C., Abdelfettah, Y., Schill, E., Mandrone, G.

“…Thermal sources are common manifestations of geothermal energy resources in Alpine regions. The up-flow of the fluid is well-known to be often linked to…”
Get full text

Use and impact of molecular methods for detecting drug-resistant TB by Molina-Moya, B., Guglielmetti, L., Bothamley, G., van Leth, F., Lange, C., Dominguez, J., TBnet Study Group

Get full text

Examples of bedaquiline introduction for the management of multidrug-resistant tuberculosis in five countries by Guglielmetti, L., Hewison, C., Avaliani, Z., Hughes, J., Kiria, N., Lomtadze, N., Ndjeka, N., Setkina, S., Shabangu, A., Sikhondze, W., Skrahina, A., Veziris, N., Furin, J.

“…BACKGROUND: For the first time in almost 50 years, there are new drugs available for the treatment of tuberculosis (TB), including bedaquiline (BDQ) and…”
Get full text

Association of smoking and alcohol use with rifampin-resistant TB treatment outcomes by Campbell, J. R., Chan, E. D., Anderson, L. F., Bonnet, M., Brode, S. K., Cegielski, J. P., Guglielmetti, L., Singla, R., Fox, G. J., Skrahina, A., Rodrigues, D., Kuksa, L., Viiklepp, P., Menzies, D.

Get full text

Clinical perspectives on treatment of rifampicin-resistant/multidrug-resistant TB by Cox, V., McKenna, L., Acquah, R., Reuter, A., Wasserman, S., Vambe, D., Ustero, P., Udwadia, Z., Triviño-Duran, L., Tommasi, M., Skrahina, A., Seddon, J. A., Rodolfo, R., Rich, M., Padanilam, X., Oyewusi, L., Ohler, L., Lungu, P., Loveday, M., Khan, U., Khan, P., Hughes, J., Hewison, C., Guglielmetti, L., Furin, J.

“…Rapid diagnostics, newer drugs, repurposed medications, and shorter regimens have radically altered the landscape for treating rifampicin-resistant TB (RR-TB)…”
Get full text

Standards for clinical trials for treating TB by du Cros, P., Greig, J., Alffenaar, J.-W. C., Cross, G. B., Cousins, C., Berry, C., Khan, U., Phillips, P. P. J., Velásquez, G. E., Furin, J., Spigelman, M., Denholm, J. T., Thi, S. S., Tiberi, S., Huang, G. K. L., Marks, G. B., Turkova, A., Guglielmetti, L., Chew, K. L., Nguyen, H. T., Ong, C. W. M., Brigden, G., Singh, K. P., Motta, I., Lange, C., Seddon, J. A., Nyang'wa, B-T., Maug, A. K. J., Gler, M. T., Dooley, K. E., Quelapio, M., Tsogt, B., Menzies, D., Cox, V., Upton, C. M., Skrahina, A., McKenna, L., Horsburgh, C. R., Dheda, K., Marais, B. J.

“…BACKGROUND: The value, speed of completion and robustness of the evidence generated by TB treatment trials could be improved by implementing standards for best…”
Get full text

Failed preoperative vacuum bell therapy does not affect outcomes following minimally invasive repair of pectus excavatum by Muff, J. L., Guglielmetti, L. C., Gros, S. J., Buchmüller, L., Frongia, G., Haecker, F. -M., Holland-Cunz, S. G., de Trey, T., Vuille-dit-Bille, Raphael N.

“…Purpose It is unknown if failed preoperative vacuum bell (VB) treatment in patients undergoing minimally invasive repair of pectus excavatum (MIRPE), delays…”
Get full text

Relative cost of multidrug-resistant TB medicines in Europe by Günther, G., Guglielmetti, L., Leu, C., van Leth, F., Lange, C.

Get full text

Cardiac Donor Risk Factors Predictive of Short-Term Heart Transplant Recipient Mortality: An Analysis of the United Network for Organ Sharing Database by Sorabella, R.A, Guglielmetti, L, Kantor, A, Castillero, E, Takayama, H, Schulze, P.C, Mancini, D, Naka, Y, George, I

“…Abstract Introduction To address the shortage of donor hearts for transplantation, there is significant interest in liberalizing donor acceptance criteria…”
Get full text

Correction to: Failed preoperative vacuum bell therapy does not affect outcomes following minimally invasive repair of pectus excavatum by Muff, J. L., Guglielmetti, L. C., Gros, S. J., Buchmüller, L., Frongia, G., Haecker, F.-M., Holland-Cunz, S. G., de Trey, T., Vuille-dit-Bille, Raphael N.

Get full text

Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial by Guglielmetti, L, Ardizzoni, E, Atger, M, Baudin, E, Berikova, E, Bonnet, M, Chang, E, Cloez, S, Coit, J. M, Cox, V, de Jong, B. C, Delifer, C, Do, J. M, Tozzi, D. Dos Santos, Ducher, V, Ferlazzo, G, Gouillou, M, Khan, A, Khan, U, Lachenal, N, LaHood, A. N, Lecca, L, Mazmanian, M, McIlleron, H, Moschioni, M, O'Brien, K, Okunbor, O, Oyewusi, L, Panda, S, Patil, S. B, Phillips, P. P. J, Pichon, L, Rupasinghe, P, Rich, M. L, Saluhuddin, N, Seung, K. J, Tamirat, M, Trippa, L, Cellamare, M, Velásquez, G. E, Wasserman, S, Zimetbaum, P. J, Varaine, F, Mitnick, C. D

“…Abstract Background Treatment of multidrug- and rifampin-resistant tuberculosis (MDR/RR-TB) is expensive, labour-intensive, and associated with substantial…”
Get full text